ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg
One-on-One Meetings
Aspire will also host virtual one-on-ones with investors on Wednesday, August 20 and Thursday, August 21, 2025. To register for the presentation or one-on ones, visit https://sidoti.com/events.
A replay of the presentation will be available on the investor relations section of Aspire’s website at https://ir.aspirebiolabs.com/events/
About Aspire Biopharma, Inc.
Aspire Biopharma has developed a patent-pending disruptive technology that can deliver supplements and drugs to the body rapidly and precisely with less negative impact to the system by going directly to the bloodstream and avoiding the gastrointestinal tract. For more information, please visit www.aspirebiolabs.com.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
How Co-Founder and President Josh Rosen Separates Real Value From Artificial Intelligence Hype in Modern…
SUNNY ISLES BEACH, FL / ACCESS Newswire / April 11, 2026 / Elektros Inc. (OTC:ELEK)…
Clark County judge finds defendant's public statements were not made in good faith. The ruling…
MMJ International Holdings Moves to Join Federal Lawsuit Challenging CMS Hemp-CBD Medicare Pilot as Preliminary…
The show will air as sponsored programming nationwide at 10:30 PM PST on Fox Business…
LOS ANGELES, CA / ACCESS Newswire / April 11, 2026 / Fatal motor vehicle collisions…